I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Pugliese, Novella
123
results:
Search for persons
X
Format
Online (123)
Mediatypes
Articles (Online) (54)
OpenAccess-fulltext (69)
Sorted by: Year
Sorted by: Relevance
?
1
Clinical outcomes of ruxolitinib treatment in 595 intermedi..:
Palandri, Francesca
;
Elli, Elena M.
;
Morsia, Erika
...
Cancer. , 2024
Link:
https://doi.org/10.1002/..
?
2
Liposomal‐encapsulated doxorubicin supercharge‐containing f..:
Picardi, Marco
;
Giordano, Claudia
;
Pugliese, Novella
...
Hematological Oncology. 42 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1002/..
?
3
P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MO..:
Palandri, Francesca
;
Auteri, Giuseppe
;
Iurlo, Alessandra
...
HemaSphere. 7 (2023) S3 - p. e4692509 , 2023
Link:
https://doi.org/10.1097/..
?
4
Liposomal‐encapsulated doxorubicin supercharge‐containing f..:
Picardi, Marco
;
Giordano, Claudia
;
Pugliese, Novella
...
Hematological Oncology. 42 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1002/..
?
5
Ultrasonography‐guided core‐needle biopsy of lymphadenopath..:
Picardi, Marco
;
Giordano, Claudia
;
Vigliar, Elena
...
Hematological Oncology. 41 (2023) 5 - p. 817-827 , 2023
Link:
https://doi.org/10.1002/..
?
6
P1050: NEXT GENERATION SEQUECING CONTRIBUTES TO DEFINE PH-N..:
Leone, Aldo
;
Conversano, Italia
;
Barbato, Serafina
...
HemaSphere. 7 (2023) S3 - p. e94036d7 , 2023
Link:
https://doi.org/10.1097/..
?
7
Predictors of Response to Hydroxyurea and Switch to Ruxolit..:
Palandri, Francesca
;
Rossi, Elena
;
Auteri, Giuseppe
...
Cancers. 15 (2023) 14 - p. 3706 , 2023
Link:
https://doi.org/10.3390/..
?
8
Lamivudine 24-month-long prophylaxis is a safe and efficien..:
Giordano, Claudia
;
Picardi, Marco
;
Pugliese, Novella
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
9
Incidence of blast phase in myelofibrosis patients accordin..:
Palandri, Francesca
;
Palumbo, Giuseppe A.
;
Benevolo, Giulia
...
Cancer. 130 (2023) 8 - p. 1270-1280 , 2023
Link:
https://doi.org/10.1002/..
?
10
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity,..:
Palandri, Francesca
;
Breccia, Massimo
;
Mazzoni, Camilla
...
Cancer. 129 (2023) 11 - p. 1704-1713 , 2023
Link:
https://doi.org/10.1002/..
?
11
A Prognostic Model to Predict Ruxolitinib Discontinuation a..:
Palandri, Francesca
;
Palumbo, Giuseppe A.
;
Bonifacio, Massimiliano
...
Cancers. 15 (2023) 20 - p. 5027 , 2023
Link:
https://doi.org/10.3390/..
?
12
PB2204: HIGH SERUM FERRITIN AT INITIAL DIAGNOSIS IS A PREDI..:
Leone, Aldo
;
Reina, Raffaella
;
Romano, Martina
...
HemaSphere. 7 (2023) S3 - p. e88230cc , 2023
Link:
https://doi.org/10.1097/..
?
13
Intravascular Complications of Central Venous Catheterizati..:
Picardi, Marco
;
Giordano, Claudia
;
Della Pepa, Roberta
...
Cancers. 15 (2023) 7 - p. 2147 , 2023
Link:
https://doi.org/10.3390/..
?
14
Cyclic Neutropenia Mimicking Crohn's Disease: Two Case Repo..:
Guarino, Alessia Dalila
;
Luglio, Gaetano
;
Imperatore, Nicola
...
Journal of Clinical Medicine. 12 (2023) 19 - p. 6323 , 2023
Link:
https://doi.org/10.3390/..
?
15
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity,..:
Palandri, Francesca
;
Breccia, Massimo
;
Mazzoni, Camilla
...
info:eu-repo/semantics/altIdentifier/pmid/36932983. , 2023
Link:
https://hdl.handle.net/1..
1-15